Imprecise excision of P{SUPor-P}GALTKG00049 resulting in a 1647-bp deletion removing virtually the entire coding region of the GALT gene, with a small remnant of the P-element sequence left behind.
1647 bp deletion resulting from the imprecise excision of P{SUPor-P}GaltKG00049, rmoves most of the Galt gene and leaves behind 13 bp of P-element sequence. Boundary sequences used to map deletion from Figure S1.
CATGATGAAATAA
GaltΔ1AP2 homozygous larvae exhibit slower movements in righting assays, as compared to controls. Their neuromuscular junctions exhibit morphological defects, as there are significantly more branches, synaptic boutons and looped boutons, as compared to controls.
GaltΔ1AP2/GaltΔ1AP2 mutants exhibit significantly decreased locomotor activity in adult flies, and larval NMJs exhibit significantly more branches and reduced inter-bouton distances, as compared to controls. GaltΔ1AP2/GaltΔ1AP2 and GaltΔ1AP2/Df(2L)BSC187 mutants exhibit defective rolling behavior in L3 larvae, taking significantly more time to roll from inverted to upright, as compared to controls; NMJs of these mutants display synaptic structural over-elaboration, with a significant increase in synaptic bouton number and synapse branch number, but mean excitatory junction current amplitude is not significantly different in GaltΔ1AP2/Df(2L)BSC187 mutants, as compared to controls.
GaltΔ1AP2 mutants fed on 555mM glucose fly food with added doses of paraquat or dimetyl sulfoxide exhibit a dose-dependent sensitivity to these compounds, with increasing quantities resulting in increasing lethality.
GaltΔ1AP2 mutants fed on fly food containing 200mM galactose exhibit increased sensitivity and lower survival rates than wild-type flies fed on fly food containing 200mM galactose. Addition of 50, 100, and 200υM paraquat to the fly food decreased survival rates even further in these mutants, while wild-type flies are affected to a lesser degree. Addition of 67, 133, or 267υM dimetyl sulfoxide to fly food containing 200mM galactose results in a dose-dependent negative impact on GaltΔ1AP2 mutant larval survival. In the absence of galactose, the addition of dimetyl sulfoxide does not affect survival except when 267υM is added, which decreases survival to pupation and eclosion by just over 10%, compared to controls.
The addition of 20, 40, and 80υM vitamin C or 40, 120, and 360υM α-mangostin to galactose containing fly food results in a significant increase in the survival rates of GaltΔ1AP2 mutants.
2-3 day old homozygous GaltΔ1AP2 mutant flies exhibit movement and climbing abnormalities that worsen profoundly with age, in contrast to the gradual, progressive decline seen in controls. Larvae raised on food supplemented with galactose, but transferred to food containing standard levels of glucose at eclosion, have an indistinguishable phenotype. GaltΔ1AP2 mutant larvae raised on galactose exhibit raised gal-1P levels during the larval stages compared to controls, but this increase is not maintained following the transfer to glucose only food at eclosion.
1-2 day old GaltΔ1AP2 mutant flies demonstrate normal configuration of major brain structures. The cortex is well preserved, as is the neuropil. Vacuoles are modest in size and number and are seen at a similar frequency to controls. Indirect flight muscles also appear structurally normal. Similar results are seen in 1 or 2 week old flies.
GaltΔ1AP2/Df(2L)Exel7027 mutant flies exhibit movement abnormalities.
Homozygous GALTΔ1AP2 or hemizygous GALTΔ1AP2/Df(2L)Exel7027 flies in the progeny of homozygous GALTΔ1AP2 mothers display galactose-dependent lethality: the mutants survive in the presence of dietary glucose, but they fail to survive if galactose is present in their food. The lethality of GALTΔ1AP2 homozygotes that are exposed to galactose occurs after first instar larval stages when feeding commences.
Despite lifelong dietary restriction of galactose, GALTΔ1AP2 homozygotes display impaired geotactic response.
GaltΔ1AP2 has uncoordinated | larval stage phenotype, enhanceable by Galeh/Galeh
GaltΔ1AP2 has uncoordinated | larval stage phenotype, enhanceable by Scer\GAL4elav.PU/GaleGD7464
GaltΔ1AP2 has uncoordinated | larval stage phenotype, enhanceable by Ugpd07256/Ugpf03515
GaltΔ1AP2 has abnormal neuroanatomy | larval stage phenotype, non-enhanceable by Galeh/Galeh
GaltΔ1AP2 has abnormal neuroanatomy | larval stage phenotype, non-enhanceable by Scer\GAL4elav.PU/GaleGD7464
GaltΔ1AP2 has uncoordinated | larval stage phenotype, non-enhanceable by Scer\GAL4how-24B/GaleGD7464
GaltΔ1AP2 has abnormal neuroanatomy | larval stage phenotype, non-enhanceable by Ugpd07256/Ugpf03515
GaltΔ1AP2 has abnormal locomotor behavior | third instar larval stage phenotype, suppressible by GalkΔEXC9/GalkΔEXC9
GaltΔ1AP2 has abnormal neuroanatomy | third instar larval stage phenotype, suppressible by GalkΔEXC9/GalkΔEXC9
GaltΔ1AP2 has abnormal locomotor behavior | third instar larval stage phenotype, suppressible by sglUY771/Scer\GAL4da.G32
GaltΔ1AP2 has abnormal neuroanatomy | third instar larval stage phenotype, suppressible by sglUY771/Scer\GAL4da.G32
GaltΔ1AP2 has abnormal locomotor behavior | third instar larval stage phenotype, suppressible by Scer\GAL4da.G32/Hsap\GALTUAS.cKa
GaltΔ1AP2 has abnormal neuroanatomy | third instar larval stage phenotype, suppressible by Scer\GAL4da.G32/Hsap\GALTUAS.cKa
GaltΔ1AP2 has abnormal locomotor behavior | adult stage phenotype, suppressible by Hsap\GALTUAS.cKa
GaltΔ1AP2 has abnormal locomotor behavior phenotype, suppressible by Scer\GAL4Act5C.PI/Hsap\GALTUAS.cKa
GaltΔ1AP2 has lethal | recessive | larval stage | chemical conditional phenotype, suppressible by Scer\GAL4Tub.PU/Hsap\GALTUAS.cKa
GaltΔ1AP2/GaltΔ1AP2 is an enhancer of uncoordinated | larval stage phenotype of GaleGD7464, Scer\GAL4elav.PU
GaltΔ1AP2/GaltΔ1AP2 is an enhancer of uncoordinated | larval stage phenotype of Galeh
GaltΔ1AP2/GaltΔ1AP2 is an enhancer of uncoordinated | larval stage phenotype of Ugpd07256/Ugpf03515
GaltΔ1AP2/GaltΔ1AP2 is an enhancer of abnormal neurophysiology | larval stage phenotype of Galeh
GaltΔ1AP2/GaltΔ1AP2 is a non-enhancer of abnormal neuroanatomy | larval stage phenotype of GaleGD7464, Scer\GAL4elav.PU
GaltΔ1AP2/GaltΔ1AP2 is a non-enhancer of abnormal neuroanatomy | larval stage phenotype of Ugpd07256/Ugpf03515
GaltΔ1AP2/GaltΔ1AP2 is a non-enhancer of abnormal neuroanatomy | larval stage phenotype of Galeh
GaltΔ1AP2/GaltΔ1AP2 is a non-suppressor of abnormal neuroanatomy | larval stage phenotype of Ugpd07256/Ugpf03515
GaltΔ1AP2 has embryonic/larval neuromuscular junction | larval stage phenotype, non-enhanceable by Galeh/Galeh
GaltΔ1AP2 has embryonic/larval neuromuscular junction | larval stage phenotype, non-enhanceable by Scer\GAL4elav.PU/GaleGD7464
GaltΔ1AP2 has embryonic/larval neuromuscular junction | larval stage phenotype, non-enhanceable by Ugpd07256/Ugpf03515
GaltΔ1AP2 has NMJ bouton | third instar larval stage phenotype, suppressible by Scer\GAL4da.G32/Hsap\GALTUAS.cKa
GaltΔ1AP2 has synapse | third instar larval stage phenotype, suppressible by Scer\GAL4da.G32/Hsap\GALTUAS.cKa
GaltΔ1AP2 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by Scer\GAL4da.G32/Hsap\GALTUAS.cKa
GaltΔ1AP2 has NMJ bouton | third instar larval stage phenotype, suppressible by GalkΔEXC9/GalkΔEXC9
GaltΔ1AP2 has synapse | third instar larval stage phenotype, suppressible by GalkΔEXC9/GalkΔEXC9
GaltΔ1AP2 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by GalkΔEXC9/GalkΔEXC9
GaltΔ1AP2 has NMJ bouton | third instar larval stage phenotype, suppressible by sglUY771/Scer\GAL4da.G32
GaltΔ1AP2 has synapse | third instar larval stage phenotype, suppressible by sglUY771/Scer\GAL4da.G32
GaltΔ1AP2 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible by sglUY771/Scer\GAL4da.G32
GaltΔ1AP2/GaltΔ1AP2 is an enhancer of embryonic/larval neuromuscular junction | larval stage phenotype of Galeh
GaltΔ1AP2/GaltΔ1AP2 is a non-enhancer of NMJ bouton | larval stage phenotype of Galeh
GaltΔ1AP2/GaltΔ1AP2 is a non-enhancer of NMJ bouton | larval stage phenotype of GaleGD7464, Scer\GAL4elav.PU
GaltΔ1AP2/GaltΔ1AP2 is a non-enhancer of NMJ bouton | larval stage phenotype of Ugpd07256/Ugpf03515
GaltΔ1AP2/GaltΔ1AP2 is a non-suppressor of NMJ bouton | larval stage phenotype of Ugpd07256/Ugpf03515
GalkΔEXC9/GalkΔEXC9 suppresses the rolling movement defects and NMJ over-elaboration phenotypes seen in GaltΔ1AP2/GaltΔ1AP2 mutant larvae.
Expression of sglUY771 under the control of Scer\GAL4da.G32 suppresses the rolling movement defects and the NMJ over-elaboration phenotypes seen in GaltΔ1AP2/GaltΔ1AP2 mutant larvae.
GALTΔ1AP2/+ genetically complements +/cup01355.
cupKG00049/+, +/GALTΔ1AP2 females are viable and fertile.
Expression of Hsap\GALTScer\UAS.cKa under the control of Scer\GAL4da.G32 suppresses the rolling movement defects and the NMJ over-elaboration phenotypes seen in GaltΔ1AP2/GaltΔ1AP2 mutant larvae.
Expression of either one or two copies of the P{UAS-hGALT.K}10A11 insertion of Hsap\GALTScer\UAS.cKa is able to significantly suppress the locomotor phenotypes seen in homozygous GaltΔ1AP2 mutant flies even in the absence of a Scer\GAL4 driver. When the P{UAS-hGALT.K}10B22 insertion of Hsap\GALTScer\UAS.cKa is expressed under the control of Scer\GAL4Act5C.PI locomotor and climbing behavior is comparable to controls.
Expression of Hsap\GALTScer\UAS.cKa driven by Scer\GAL4tub.PU rescues the galactose-dependent lethality in GALTΔ1AP2 homozygotes.